| Literature DB >> 34256730 |
Yujuan Yue1, Qiyong Liu2, Xiaobo Liu2, Haixia Wu2, Mingfang Xu2,3.
Abstract
BACKGROUND: In China, Guangdong and Yunnan are the two most dengue-affected provinces. This study aimed to compare the epidemiological characteristics of dengue fever in Guangdong and Yunnan during 2004-2018.Entities:
Keywords: Comparative analyses; Demographic; Epidemiological characteristics; Guangdong; Spatial; Temporal; Yunnan
Mesh:
Year: 2021 PMID: 34256730 PMCID: PMC8278621 DOI: 10.1186/s12889-021-11323-5
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Summary of diagnosis criteria and classification for dengue [11]
| Variable | Diagnostic Criteria and Principle of Management of Dengue Fever | Diagnostic Criteria for Dengue Fever |
|---|---|---|
| Issued by | Chinese Ministry of Health | Chinese Ministry of Health |
| Date issued | 23 November 2001 | 28 February 2008 |
| Date enforced | 1 May 2002 | 1 September 2008 |
| Epidemiologic Linkage | 1.1 Living in or travel to a dengue endemic country/region or presence at location with ongoing outbreak within previous 15 days of dengue-like illness, and reported being bitten by mosquito within 5–9 days of illness onset. | 1.1 Travel to a dengue endemic country/region within previous 14 days of dengue-like illness. 1.2 Around the place of residence or place of work (e.g. 100 m radius), there have been dengue case(s) within one month. |
| Clinical description | 2.1 Sudden onset, chills and fever (39–40 °C within 24-36 h, a small number of patients showed a biphasic fever), with symptoms such as fatigue, nausea and/or vomiting. 2.2 Aches and pains (e.g., headache, retro-orbital pain, joint pain, myalgia, arthralgia). 2.3 Flushed skin on face, neck and chest, and conjunctival congestion. 2.4 Superficial lymphadenopathy. 2.5 Measles-like rash, scarlatiniform rash, and/or petechiae in the limbs, trunk, head and face in the course of illness (days 5–7); itching; no scaling; continued 3-5d. 2.6 Encephalitis, encephalopathy, or meningitis-like neurological disorders. 2.7 Bleeding tendency (tourniquet test positive): occurs in the course of illness (days 5–8) with gingival bleeding, nose bleeding, gastrointestinal bleeding, subcutaneous hemorrhage, hematuria, hemoptysis, and vaginal bleeding, and/or chest and abdominal cavity bleeding, etc. 2.8 Multiple organ bleeding. 2.9 Liver enlargement. 2.10 Shock. | 2.1 Sudden onset, fever (39–40 °C within 24-36 h, someone shows biphasic fever); severe headache, retro-orbital pain, myalgia, arthralgia and fatigue; flushed skin on face, neck and chest, and conjunctival congestion, etc. 2.2 Rash: measles-like rash, scarlatiniform rash, and/or needle-like hemorrhagic rash in the limbs, trunk, head and face in the course of illness (days 5–7); itching; no scaling; continued 3-5d. 2.3 Bleeding tendency (tourniquet test positive): petechia, ecchymoses, purpura and injection site bleeding, or bleeding from the mucous membranes of mouth and nose, gastrointestinal bleeding, hemoptysis, hematuria and vaginal bleeding in the course of illness (days 5–8). 2.4 Massive hemorrhage of gastrointestinal tract, or chest and abdominal cavity bleeding, or intracranial hemorrhage. 2.5 Liver enlargement, pleural or pericardial effusion. 2.6 Shock syndrome: clammy skin, restlessness, rapid and weak pulse and narrow pulse pressure < 20 mmHg (2.7 kPa) and undetectable in blood pressure, oliguria etc. |
| Diagnosis and Classification | 3.1 Thrombocytopenia (< 100 × 109/L). White blood cell count decrease, lymphocytes and mononuclear cell count increase. 3.2 Hematocrit increased more than 20%. 3.3 IgG anti-DENV positive in a serum specimen. 3.4 IgM anti-DENV positive in a serum specimen. 3.5 IgG anti-DENV ≥4-fold rise in titer in paired acute and convalescent serum specimens. The serologic tests included enzyme-linked immunosorbent assay (ELISA), HI, CF, immunofluorescence method (FA/IFA), Dengue blot (DB), and NT. 3.6 Cell culture isolation of DENV by | 3.1 A total white blood cell count decrease. 3.2 Thrombocytopenia (< 100 × 109/L). 3.3 Hemoconcentration (an increase in hematocrit ≥20% above average for age or a decrease in hematocrit ≥20% of baseline following fluid replacement therapy); hypoproteinemia. 3.4 IgG or IgM anti-DENV positive in a serum specimen. 3.5 Cell culture isolation of DENV by 3.6 IgG anti-DENV ≥4-fold rise in titer in paired acute and convalescent serum samples. The serologic tests included ELISA, mac-ELISA, HI, FA/IFA, NT. 3.7 Detection of DENV nucleic acid by RT-PCR or real-time fluorescence quantitative PCR. |
| Diagnosis and Classification | 4.1 Suspected case: a patient with item 1.1, 2.1 and 2.2, and one of item 2.3 to 2.7, as defined above. 4.2 Probable case: a suspected case with item 3.1 in a confirmed outbreak, or a suspected case with item 3.1 and 3.3 in an unconfirmed outbreak or presented as a sporadic case. 4.3 Confirmed case: DF: a probable case with one of item 3.4, 3.5 and 3.6. DHF: a confirmed DF case with item 2.8, 2.9 and 3.2. DSS: a confirmed DHF case with item 2.10. | 4.1 Suspected case: a patient with item 1.1 and 2.1, or a patient with item 2.1, 3.1 and 3.2, as defined above. 4.2 Probable case: DF: a suspected case with 1.2, 3.1 and 3.2; or a suspect case with item 2.1, 3.1, 3.2 and 3.4. DHF: a probable case of DF with item 3.2, 3.3 and one of item 2.3 to 2.5. DSS: a probable case of DHF with item 2.6. 4.3 Confirmed case: a probable case with one of item 3.5 to 3.7. |
General information comparison between GD and YN, China
| Population in 2010 | Area (km2) | Administrative divisions | Average yearly incidence rate of indigenous dengue fever in 2004–2018 (1/100000) | Average yearly incidence rate of imported dengue fever in 2004–2018 (1/100000) | |
|---|---|---|---|---|---|
| GD | 104,409,400 | 177,548 | 123 counties in 21 cities | 3.65 | 0.07 |
| YN | 46,016,000 | 383,966 | 129 counties in 16 cities | 0.86 | 0.44 |
Fig. 1Temporal distribution mapping of indigenous dengue fever in GD and YN, 2004–2018. a Yearly indigenous fever. b Monthly indigenous fever
Fig. 2Spatial distribution of indigenous dengue fever in GD and YN, 2004–2018. a The study area. b Indigenous dengue incidence rate. (Fig. 2 was created using ArcGIS version 10.5 by ourselves. Its license number was SO20160927002)
Information comparison of dengue fever by gender in GD and YN, 2004–2018
| Gender | Indigenous cases/proportions(%) | Imported cases/proportions(%) | ||
|---|---|---|---|---|
| GD | YN | GD | YN | |
| Male | 27,760/49.6 | 2843/47.9 | 765/66.8 | 1638/53.7 |
| Female | 28,210/50.4 | 3095/52.1 | 381/33.2 | 1412/46.3 |
| Total | 55,970/100.0 | 5938/100.0 | 1146/100.0 | 3050/100.0 |
Information comparison of dengue fever by age group in GD and YN, 2004–2018
| Age group | Indigenous cases/proportions(%) | Imported cases/proportions(%) | ||
|---|---|---|---|---|
| GD | YN | GD | YN | |
| 0–10 | 2661/4.8 | 287/4.8 | 8/0.7 | 294/9.6 |
| 11–20 | 4675/8.4 | 635/10.7 | 60/5.2 | 444/14.6 |
| 21–30 | 12,003/21.4 | 1350/22.7 | 379/33.1 | 842/27.6 |
| 31–40 | 10,267/18.3 | 1196/20.1 | 369/32.2 | 600/19.7 |
| 41–50 | 9782/17.5 | 1182/19.9 | 206/18.0 | 467/15.3 |
| 51–60 | 7539/13.5 | 710/12.0 | 83/7.2 | 258/8.5 |
| 61–70 | 5019/9.0 | 348/5.9 | 34/3.0 | 107/3.5 |
| 71- | 4024/7.2 | 230/3.9 | 7/0.6 | 38/1.2 |
| Total | 55,970/100.0 | 5938/100.0 | 1146/100.0 | 3050/100.0 |
Information comparison of dengue fever by occupation group in GD and YN, 2004–2018
| Occupation | Indigenous cases/proportions(%) | Imported cases/proportions(%) | ||
|---|---|---|---|---|
| GD | YN | GD | YN | |
| Cadre | 1740/3.1 | 278/4.7 | 102/8.9 | 49/1.6 |
| Worker | 5566/9.9 | 322/5.4 | 193/16.8 | 97/3.2 |
| House worker or unemployed | 13,030/23.3 | 760/12.8 | 174/15.2 | 199/6.5 |
| Retiree | 7065/12.6 | 546/9.2 | 39/3.4 | 18/0.6 |
| Rural laborer | 1046/1.9 | 149/2.5 | 16/1.4 | 75/2.5 |
| Farmer | 2957/5.3 | 807/13.6 | 31/2.7 | 1122/36.8 |
| Businessman | 6336/11.3 | 1427/24.0 | 301/26.3 | 712/23.3 |
| Student | 4287/7.7 | 480/8.1 | 58/5.1 | 384/12.6 |
| Children | 1463/2.6 | 140/2.4 | 6/0.5 | 155/5.1 |
| Else | 1652/3.0 | 367/6.2 | 54/4.7 | 76/2.5 |
| Unavailable | 10,828/19.3 | 662/11.1 | 172/15.0 | 163/5.3 |
| Total | 55,970/100.0 | 5938/100.0 | 1146/100.0 | 3050/100.0 |
Fig. 3Temporal distribution mapping of imported dengue fever in GD and YN, 2004–2018. a Yearly imported fever. b Monthly imported fever
Fig. 4Spatial distribution of imported dengue fever in GD and YN, 2004–2018. (Fig. 4 was created using ArcGIS version 10.5 by ourselves. Its license number was SO20160927002)
Fig. 5Spatial distribution of the origins of imported dengue fever in GD and YN, 2004–2018. (Fig. 5 was created using ArcGIS version 10.5 by ourselves. Its license number was SO20160927002)
GDP comparison in GD and YN, 2018
| GD | YN | |
|---|---|---|
| GDP (0.1Billion RMB) | 97,277.77 | 17,881.12 |
| The primary industry (0.1Billion RMB) | 3831.44 | 2498.86 |
| The secondary industry (0.1Billion RMB) | 40,695.15 | 6975.44 |
| The third industry (0.1Billion RMB) | 52,751.18 | 8424.82 |
| Per capita GDP (RMB/Person) | 86,412 | 37,136 |
Fig. 6Monthly temperature and monthly rainfall in GD and YN, 2004–2018